Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

PTPN3 suppresses lung cancer cell invasiveness by counteracting Src-mediated DAAM1 activation and actin polymerization.

Li MY, Peng WH, Wu CH, Chang YM, Lin YL, Chang GD, Wu HC, Chen GC.

Oncogene. 2019 Oct;38(44):7002-7016. doi: 10.1038/s41388-019-0948-6. Epub 2019 Aug 12.

PMID:
31406243
2.

Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.

Wu CH, Lan CH, Wu KL, Wu YM, Jane WN, Hsiao M, Wu HC.

Int J Oncol. 2018 Feb;52(2):389-401. doi: 10.3892/ijo.2017.4205. Epub 2017 Nov 16.

3.

A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia in mice.

Liu CH, Chern GJ, Hsu FF, Huang KW, Sung YC, Huang HC, Qiu JT, Wang SK, Lin CC, Wu CH, Wu HC, Liu JY, Chen Y.

Hepatology. 2018 Mar;67(3):899-913. doi: 10.1002/hep.29513. Epub 2018 Jan 29.

PMID:
28885731
4.

Advancement and applications of peptide phage display technology in biomedical science.

Wu CH, Liu IJ, Lu RM, Wu HC.

J Biomed Sci. 2016 Jan 19;23:8. doi: 10.1186/s12929-016-0223-x.

5.

α-Enolase-binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer.

Wu CH, Kuo YH, Hong RL, Wu HC.

Sci Transl Med. 2015 Jun 3;7(290):290ra91. doi: 10.1126/scitranslmed.aaa9391.

PMID:
26041708
6.

A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer.

Chang DK, Lin CT, Wu CH, Wu HC.

PLoS One. 2009;4(1):e4171. doi: 10.1371/journal.pone.0004171. Epub 2009 Jan 12.

Supplemental Content

Loading ...
Support Center